BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹1.10 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.00 Cr | - |
What is the latest Deferred Tax Assets / Liabilities ratio of BALAXI PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹1.10 Cr |
Mar2022 | ₹0.04 Cr |
Mar2021 | ₹0.01 Cr |
Mar2020 | ₹0.00 Cr |
Mar2019 | - |
How is Deferred Tax Assets / Liabilities of BALAXI PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹1.10 Cr | 2,723.08 | |
Mar2022 | ₹0.04 Cr | 457.14 | |
Mar2021 | ₹0.01 Cr | 133.33 | |
Mar2020 | ₹0.00 Cr | 0 | |
Mar2019 | - | - |
Compare Deferred Tax Assets / Liabilities of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹656.8 Cr | -2.6% | 3.2% | 13.4% | Stock Analytics | |
ADANI ENTERPRISES | ₹326,052.0 Cr | -7.2% | -12.4% | 56.4% | Stock Analytics | |
REDINGTON | ₹16,096.7 Cr | -4.5% | -6% | 21.6% | Stock Analytics | |
HONASA CONSUMER | ₹14,000.9 Cr | -0.9% | 4% | NA | Stock Analytics | |
MMTC | ₹10,620.0 Cr | -4.8% | -8.3% | 152.6% | Stock Analytics | |
MSTC | ₹5,814.7 Cr | -8.6% | -11.8% | 194.4% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | -2.6% |
3.2% |
13.4% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses